Background Thrombotic events continue to be a major cause of morbidity and mortality
worldwide. Tissue plasminogen activator (tPA) is used for the treatment of acute ischemic …

Background Magnetic nanoparticles (MNPs) hold promise for enhancing delivery of
therapeutic agents, either through direct binding or by functioning as miniature propellers …